RAC1 Takes the Lead in Solid Tumors
نویسندگان
چکیده
منابع مشابه
Cofilin takes the lead.
Cofilin has emerged as a key regulator of actin dynamics at the leading edge of motile cells. Through its actin-severing activity, it creates new actin barbed ends for polymerization and also depolymerizes old actin filaments. Its function is tightly regulated in the cell. Spatially, its activity is restricted by other actin-binding proteins, such as tropomyosin, which compete for accessibility...
متن کاملSIRT1 takes down tumors
SIRT1 takes down tumors Y uan et al. have identifi ed another anti-cancer effect of the “longevity” protein SIRT1. By speeding the destruction of the tumor promoter c-Myc, SIRT1 curbs cell division. The yeast and nematode equivalents of SIRT1 are fountains of youth that stretch lifespan. Whether SIRT1 slows aging in mammals isn’t certain, but it’s benefi cial in other ways. The protein tunes up...
متن کاملA polarity factor takes the lead in chromosome segregation.
Little is known about how rapid and accurate chromosome segregation, a vital step that must be completed before cell division, is achieved in bacterial cells. Several studies, including one by Schofield et al in this issue of The EMBO Journal, now shed light on this process by elucidating novel interactions between the chromosome partitioning system ParAB-parS, the polarity determinant TipN and...
متن کاملRoss Baker takes the lead: our new Editor-in-Chief.
Ross Baker’s LinkedIn profile is impressive but incomplete. He does not, for example, announce yet that he is editor-in-chief of the journal Healthcare Quarterly, a significant milestone for this upstart publishing venture. Ross was formerly associate editor of the journal in support of our founding editor, Peggy Leatt. This development should not come as a surprise to our readers; Ross has bee...
متن کاملTargeting axonal regeneration: the growth cone takes the lead.
Laura Montani1* and Marija M. Petrinovic2,3* 1Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH, Zurich, CH-8093, Zurich, Switzerland, 2F. Hoffmann-La Roche, pRED, Pharma Research and Early Development, DTA Neuroscience, Ophthalmology and Rare Diseases, CH-4070 Basel, Switzerland, and 3Biozentrum, University of Basel, CH-4056, Basel, Switzerland Review of Stern ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cells
سال: 2019
ISSN: 2073-4409
DOI: 10.3390/cells8050382